MSI-H/ MMRd
我们是谁
TAS-102 加放射疗法治疗结直肠癌肝转移患者肝脏的研究
评估自体钙粘蛋白 17 嵌合抗原受体 (CAR) T 细胞疗法 CHM-2101 的 1/2 期研究
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms
Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer
CA102N 联合 TAS-102 与贝伐珠单抗联合 TAS-102 治疗复发性和/或难治性转移性结直肠癌受试者的 2 期研究比较
针对转移性结直肠癌受试者的 CNA3103（LGR5 靶向自体 CAR-T 细胞）研究
RC48-ADC 联合贝伐单抗治疗 HER2 阳性晚期结直肠癌
Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
